Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

A Tale of Two Drugs: Meridia and Avandia, and the Issues that Separated Them

Nov 01 2010

• By Kate Rawson

Related Content

Regulating in Real Time: Avandia and the Challenges of Making "Sound Decisions" Under Heavy Scrutiny

Nov 01 2010

How FDA Withdraws A Drug

Oct 01 2010

Avandia Revisited: Will New Findings Lead To Reevaluation of Drug Center's Structure?

Feb 01 2010

Inside the Mind of a Serial Drug Killer

Jul 01 2007

FDA's Brilliant Management of Avandia Re-Review Provides Flexibility on Final Decision

Sep 01 2010

Related Companies

Abbott

GSK plc

Pfizer Inc.

Takeda Pharmaceutical Co. Ltd.

Wyeth

Vivus, Inc.

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window